ResMed Inc. (NYSE:RMD) will look for acquisitions. Chief Financial Officer, Brett Sandercock said, “Going forward, we plan to continue to reinvest for growth through R&D. We also expect to continue to deploy capital for tuck-in acquisitions such as Citus Health and Ectosense, an acquisition we completed on October 1, 2021”.